• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Conceptus Inc.

Birth control battle continues as Hologic appeals and Conceptus pursues injunction | Legal News

February 8, 2012 By MassDevice staff Leave a Comment

Health care law

The patent war over a female contraceptive device continues as Hologic (NSDQ:HOLX) seeks to overturn a $18.8 million patent loss and Conceptus’ (NSDQ:CPTS) pursues a permanent injunction to keep Hologic’s Adiana device off the U.S. market.

Filed Under: Electronic Medical Records (EMR), Legal News, News Well, Patent Infringement, Women's Health Tagged With: Conceptus Inc., Hologic

MassDevice.com +3 | MassDevice Q&A with Medtronic CEO Omar Ishrak, Judge strikes down Conceptus’ injuction against Hologic and CMS blames economy for health care spending drop

January 10, 2012 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Healthcare Reform, News Well, Patent Infringement Tagged With: Centers for Medicare and Medicaid Services (CMS), Conceptus Inc., Hologic

Judge strikes down Conceptus’ request for an injunction against Hologic

January 10, 2012 By MassDevice staff Leave a Comment

A California judge denied Conceptus’ (NSDQ:CPTS) request for a permanent injunction against Hologic (NSDQ:HOLX), from selling its Adiana female sterilization technology in the United States.

Filed Under: Implants, Legal News, News Well, Patent Infringement, Women's Health Tagged With: Conceptus Inc., Hologic

Conceptus swaps out $50 million in senior notes | Funding Roundup

January 3, 2012 By MassDevice staff Leave a Comment

Conceptus Inc. logo

Conceptus (NSDQ:CPTS) swapped out $50 million worth of 2.25% senior notes due 2027 from a select group of holders, exchanging them for 5% notes due 2031, regulatory filings show.

The principal amount on the new notes was an even swap for the originals, which was determined in individual negotiations between Conceptus and the holders.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Clearflow, Conceptus Inc., iCad Inc., Lucid Inc., ProUroCare Medical Inc., Velomedix Inc.

New Conceptus CEO expects boost from ACA | Wall Street Beat

January 2, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The Affordable Care Act’s provision covering contraception could be an "inflection point" for Conceptus (NSDQ:CPTS) and its Essure female sterilization system, new CEO Keith Grossman told Leering Swann analysts last month.

Filed Under: News Well, Wall Street Beat, Women's Health Tagged With: Abbott, Amgen, Baxter, Boston Scientific, C.R. Bard, Computer Sciences Corp., Conceptus Inc., Golden Meditech Holdings Ltd., Hologic, Intuitive Surgical, Johnson and Johnson, Kensey Nash Corp., stjudemedical

Conceptus CFO reveals 2011 EBIDTA expectations | Wall Street Beat

December 23, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

 Conceptus CFO says 2011 EBIDTA could reach $14M

Filed Under: News Well, Wall Street Beat, Women's Health Tagged With: Abbott, Abiomed, Amgen, Baxter, C.R. Bard, Conceptus Inc., Golden Meditech Holdings Ltd.

Conceptus names new CEO, lowers 2012 guidance | Personnel Moves

December 8, 2011 By MassDevice staff Leave a Comment

Conceptus logo

In a sudden switch, Conceptus (NSDQ:CPTS) named Keith Grossman president & CEO upon the resignation of Mark Sieczkarek, whose departure was announced on the heels of lowered sales guidance for 2012.

Sieczkarek’s resignation, after 7 years at the helm, was announced simultaneously with Grossman’s appointment. Grossman will join the company’s board of directors, from which Sieczkarek also resigned.

Filed Under: Gynecological, Legal News, News Well, Wall Street Beat, Women's Health Tagged With: Conceptus Inc., Dara Biosciences Inc., Hologic, OrthoAccel Technologies Inc., Personnel Moves, Quest Diagnostics Inc.

Masimo plunges after missing Q3 earnings target | Earnings Roundup

October 26, 2011 By MassDevice staff Leave a Comment

Masimo

Shares of Masimo Corp. (NSDQ:MASI) plunged more than 12 percent today after the patient monitoring device maker missed third-quarter earnings expectations and lowered its sales and earnings guidance for the rest of 2011.

MASI shares were trading at $19.61 as of about 1 p.m. today, down 12.1 percent.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Allergan, Conceptus Inc., Fujifilm, Hospira Inc., Masimo, McKesson Corp., Merit Medical Systems, Q3, Spectranetics Corp., STAAR Surgical Co, vascularsolutions

Conceptus aims for injunction against Hologic in $19 million patent spat | MassDevice.com On Call

October 21, 2011 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Conceptus (NSDQ:CPTS) intends to pursue an injunction against Hologic (NSDQ:HOLX) on the face of a recent legal win.

Earlier this week, a California jury awarded Conceptus $19 million and a 20 percent royalty in a patent spat over female sterilization technology.

Filed Under: Healthcare Reform, Legal News, News Well, Pain Management, Patent Infringement Tagged With: 510(k) reforms, Conceptus Inc., Hologic, Insurance

UPDATE: Hologic owes Conceptus $19M in patent fight

October 19, 2011 By MassDevice staff Leave a Comment

Conceptus
Hologic

UPDATED 10/18/2011 with comment from Hologic

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Conceptus Inc., Hologic

Wall Street Beat: Goldman Sachs raises COV estimate; Nygren shucks JNJ position, adds to BAX

August 31, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Roundup

MASSDEVICE WALL STREET ROUNDUP | One of Wall Street’s most notorious names raised its view of Covidien plc (NYSE:COV) today, setting a price target that’s 15 percent above yesterday’s closing price.

Although Goldman Sachs analysts stood pat on their “Buy” rating of the stock, which ended Monday at $52, they raised their price target to $60 and boosted the stock’s earnings estimate, ahead of the company’s plan to buy back up to 5 million shares of its own stock.

COV shares closed up 0.2 percent today at $52.08.

Filed Under: News Well Tagged With: Aura Biosciences, Baxter, Cardiofocus, Conceptus Inc., Covidien, Debt Financing, Johnson and Johnson, Lantos Technologies Inc., Varian Medical Systems, Venture Capital/Private Equity

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS